Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.75 USD | +2.44% | +2.13% | -11.69% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- With a 2024 P/E ratio at 25.57 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.69% | 5.17B | B- | ||
+17.73% | 83.46B | C+ | ||
-32.08% | 67.33B | B- | ||
-3.10% | 25.66B | C+ | ||
+4.20% | 17.91B | A- | ||
-13.68% | 16.54B | B | ||
+0.75% | 15.43B | A- | ||
+74.92% | 13.46B | C- | ||
+73.16% | 12.78B | C+ | ||
-2.02% | 12.33B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OPCH Stock
- Ratings Option Care Health, Inc.